GT Biopharma Announces 1-for-30 Reverse Stock Split
Company Announcements

GT Biopharma Announces 1-for-30 Reverse Stock Split

GT Biopharma (GTBP) has released an update to notify the public and investors about a material modification to rights of security holders.

GT Biopharma, Inc. has filed to effect a 1-for-30 reverse stock split of its common stock, which will take place on February 2, 2024, at 5:00 p.m. Eastern time. This action will combine every thirty shares into one and will reduce the total outstanding shares from 41,419,000 to approximately 1,380,633. Fractional shares will not be issued; instead, shareholders will receive cash for their fractional entitlements. The authorized share count remains unchanged, and adjustments will be made to outstanding stock options and incentive plans. The stock will trade on a split-adjusted basis under the same symbol “GTBP” with a new CUSIP number starting February 5, 2024.

For further insights into GTBP stock, check out TipRanks’ Stock Analysis page.

For a comprehensive understanding of the announcement, you can read the full document here.

Related Articles
TipRanks Auto-Generated NewsdeskGT Biopharma’s Dr. Miller Assumes New Medical Director Role
TheFlyOne new option listing and eighteen option delistings on July 22nd
TheFlyGT Biopharma announces FDA clearance of IND application for GTB-3650
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App